Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric carcinoids.

C Bordi1

  • 1Institute of Anatomic Pathology, University of Parma, Italy.

Italian Journal of Gastroenterology and Hepatology
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Gastric carcinoids are classified into three types based on pathological associations. Types I and II share a similar pathogenesis involving hypergastrinaemia, while Type III tumors are sporadic, often malignant, with unclear origins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.

British journal of cancer·2013
Same author

Development of type I gastric carcinoid in patients with chronic atrophic gastritis.

Alimentary pharmacology & therapeutics·2011
Same author

Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2011
Same author

Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.

Alimentary pharmacology & therapeutics·2010
Same author

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.

British journal of cancer·2007
Same author

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.

Endocrine-related cancer·2006
Same journal

Treatment of rectal cancer--a critical update.

Italian journal of gastroenterology and hepatology·2000
Same journal

Spectrum of acute self-limiting colitis: role of the clinician and pathologist.

Italian journal of gastroenterology and hepatology·2000
Same journal

Immunodeficiency and the gut: clues to the role of the immune system in gastrointestinal disease.

Italian journal of gastroenterology and hepatology·2000
Same journal

New and future drugs in nerve-gut dysfunction.

Italian journal of gastroenterology and hepatology·2000
Same journal

Therapy of chronic viral hepatitis: a critical view.

Italian journal of gastroenterology and hepatology·2000
Same journal

Coeliac disease in the year 2000.

Italian journal of gastroenterology and hepatology·2000
See all related articles

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Oncology

Background:

  • Gastric carcinoids are neuroendocrine tumors of the stomach.
  • Classification is based on pathological associations: Type I (atrophic gastritis), Type II (MEN1), and Type III (sporadic).
  • Types I and II carcinoids progress through hyperplasia, dysplasia, and neoplasia.

Purpose of the Study:

  • To review the classification, pathogenesis, and prognosis of gastric carcinoids.
  • To differentiate the etiological factors and clinical behavior of the three gastric carcinoid types.

Main Methods:

  • Review of existing literature on gastric carcinoid classification and pathogenesis.
  • Pathological and clinical data analysis for different gastric carcinoid types.

Related Experiment Videos

Main Results:

  • Type I and II gastric carcinoids are linked to hypergastrinaemia and share a common developmental pathway.
  • Type III gastric carcinoids are sporadic, frequently malignant, and their pathogenesis remains largely unknown.
  • Prognosis for Type I and II gastric carcinoids is generally favorable, contrasting with the often aggressive nature of Type III.

Conclusions:

  • Gastric carcinoid classification effectively distinguishes tumors with different underlying mechanisms and clinical outcomes.
  • Understanding the role of hypergastrinaemia and other factors is crucial for Type I and II carcinoid pathogenesis.
  • Further research is needed to elucidate the pathogenesis of sporadic (Type III) gastric carcinoids.